@article{530fe557a7e94387b13de903403bb1d8,
title = "Reloading When Switching From Ticagrelor or Prasugrel to Clopidogrel Within 7 Days After STEMI",
author = "Claassens, \{Daniel M. F.\} and Tavenier, \{Anne H.\} and Hermanides, \{Renicus S.\} and Vos, \{Gerrit J. A.\} and Hinrichs, \{Dario L.\} and Bergmeijer, \{Thomas O.\} and \{van't Hof\}, \{Arnoud W. J.\} and Deneer, \{Vera H. M.\} and \{ten Berg\}, \{Jurrien M.\}",
note = "Funding Information: The authors thank Pim van der Harst, MD, PhD, Emanuele Barbato, MD, PhD, Carmine Morisco, MD, PhD, Melvyn Tjon Joe Gin, MD, Folkert Asselbergs, MD, PhD, Arend Mosterd, MD, PhD, Jean-Paul Herrman, MD, PhD, Paul Janssen, MD, PhD, Hans Kelder, MD, PhD, and Willem Dewilde, MD, PhD, for their efforts in conducting this trial. Please note: ?Drs. Claassens and Tavenier contributed equally to this work. This trial was conducted on a government grant from The Netherlands Organisation of Health Research and Development (project number 171102022 assigned to Dr. Deneer). Spartan Bioscience Inc. (Ottawa, Canada) provided the point-of-care system and testing reagents used for free. Dr. ten Berg has received speaker fees from AstraZeneca, Boehringer Ingelheim, Bayer, and Daiichi-Sankyo; and has received an institutional research grant from AstraZeneca. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.",
year = "2020",
month = mar,
day = "9",
doi = "10.1016/j.jcin.2020.01.001",
language = "English",
volume = "13",
pages = "663--665",
journal = "Jacc-Cardiovascular Interventions",
issn = "1936-8798",
publisher = "Elsevier Inc.",
number = "5",
}